aPCC vs. rFVIIa for the treatment of bleeding in patients with acquired haemophilia - a cost-effectiveness model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

aPCC vs. rFVIIa for the treatment of bleeding in patients with acquired haemophilia - a cost-effectiveness model

Published:2018-11-30 Issue:1 Volume:114 Page:63-72
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Kim Chong H.¹,Simmons Sierra C.²,Bui Chau M.²,Jiang Ning³,Pham Huy P.⁴^ORCID

Affiliation:

1. Department of Clinical Pharmacy; University of Colorado Anschutz Medical Campus; Aurora CO USA

2. Independent Researcher; Reno NV USA

3. Center for Family Life at Sunset Park; SCO Family of Services; Brooklyn NY USA

4. Department of Pathology; Keck School of Medicine; University of Southern California; Los Angeles CA USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12726/fullpdf

Reference35 articles.

1. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors;Delgado;Br J Haematol,2003

2. Acquired hemophilia A: updated review of evidence and treatment guidance;Kruse-Jarres;Am J Hematol,2017

3. Acquired hemophilia A: a review of recent data and new therapeutic options;Franchini;Hematology,2017

4. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation;Collins;Blood,2007

5. A population based, unselected, consecutive cohort of patients with acquired haemophilia A;Collins;Br J Haematol,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India;Heliyon;2024-03

2. Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies;PharmacoEconomics;2023-08-18

3. ACQUIRED HAEMOPHILIA A: AN INTRIGUING DISEASE;Mediterranean Journal of Hematology and Infectious Diseases;2020-06-28

4. An economic analysis of different treatments for bleeding in patients with acquired haemophilia;Vox Sanguinis;2020-04

5. Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis;Vox Sanguinis;2020-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3